Geode Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-320,642
| Closed | -$56K | – | 5049 |
|
|
2022
Q3 | $56K | Hold |
320,642
| – | – | ﹤0.01% | 4743 |
|
|
2022
Q2 | $192K | Hold |
320,642
| – | – | ﹤0.01% | 4293 |
|
|
2022
Q1 | $423K | Buy |
320,642
+40,239
| +14% | +$53.1K | ﹤0.01% | 4024 |
|
|
2021
Q4 | $731K | Sell |
280,403
-186
| -0.1% | -$485 | ﹤0.01% | 3858 |
|
|
2021
Q3 | $872K | Buy |
280,589
+84,729
| +43% | +$263K | ﹤0.01% | 3750 |
|
|
2021
Q2 | $728K | Sell |
195,860
-45,653
| -19% | -$170K | ﹤0.01% | 3757 |
|
|
2021
Q1 | $835K | Buy |
241,513
+9,477
| +4% | +$32.8K | ﹤0.01% | 3627 |
|
|
2020
Q4 | $779K | Sell |
232,036
-4,156
| -2% | -$14K | ﹤0.01% | 3444 |
|
|
2020
Q3 | $829K | Buy |
236,192
+10,258
| +5% | +$36K | ﹤0.01% | 3277 |
|
|
2020
Q2 | $1.04M | Buy |
225,934
+11,275
| +5% | +$51.9K | ﹤0.01% | 3125 |
|
|
2020
Q1 | $710K | Buy |
214,659
+24,942
| +13% | +$82.5K | ﹤0.01% | 3151 |
|
|
2019
Q4 | $1.16M | Buy |
189,717
+7,371
| +4% | +$45K | ﹤0.01% | 3226 |
|
|
2019
Q3 | $760K | Buy |
182,346
+251
| +0.1% | +$1.05K | ﹤0.01% | 3331 |
|
|
2019
Q2 | $2.39M | Buy |
182,095
+105,791
| +139% | +$1.39M | ﹤0.01% | 2834 |
|
|
2019
Q1 | $725K | Buy |
+76,304
| New | +$725K | ﹤0.01% | 3289 |
|